ASCO annual meeting features clinical trial results of immunotherapy for bladder and kidney cancer
With recent FDA approvals of immunotherapy drugs for kidney and bladder cancer, patients now have more options to consider among their treatments. The 2016 ASCO… Read More »ASCO annual meeting features clinical trial results of immunotherapy for bladder and kidney cancer